首页|新型选择性半胱氨酰白三烯受体1(CysLT1R)拮抗剂的设计合成及构效关系研究

新型选择性半胱氨酰白三烯受体1(CysLT1R)拮抗剂的设计合成及构效关系研究

扫码查看
半胱氨酰白三烯(CysLTs)是炎症脂介质,其受体(CysLTsR)在哮喘、过敏性鼻炎和癌症等疾病的发生发展中发挥重要作用。已发现3-取代1H-吲哚-2-羧酸衍生物具有半胱氨酰白三烯受体1(CysLT1R)拮抗活性,但较差的溶解度限制了其进一步研究。基于已有研究基础继续进行结构优化,设计合成了多个系列化合物,其中3-{2-[(1E)-3-({3-[(1E)-2-(7-氯喹啉-2-基)乙烯基]苯基}氨基)-3-氧亚基丙-1-烯基]苯基}丙酸(T9)展现出良好的选择性CysLT1受体拮抗活性和改善的溶解度,其IC50值为(0。0066±0。0023)μmol/L,在水中溶解度为4。16× 10-5 g/mL。
Design,Synthesis,and Structure-Activity Relationship of Novel Potent and Highly Selective Cysteinyl Leukotriene Receptor 1(CysLT1R)Antagonists
Cysteinyl leukotrienes(CysLTs)are lipid mediators of inflammation,and their receptors(CysLTsR)play an essen-tial role in asthma,allergic rhinitis,cancer,andother diseases.According to earlier studies,3-substituted lH-indole-2-car-boxylic acid derivatives displayed selective cysteinyl leukotriene receptor 1(CysLT1R)antagonistic activity,while their poor water solubility restricted their further evaluation.Hence,structural optimization was continued and multiple series of com-pounds were designed and synthesized based on existing research foundations.Among them,3-(2-((E)-3-((3-((E)-2-(7-chloro-quinolin-2-yl)vinyl)phenyl)amino)-3-oxoprop-1-en-1-yl)phenyl)propanoic acid(T9)exhibits good selective CysLT1 receptor antagonistic activity and improved solubility,with IC50 value of(0.0066±0.0023)μmol/L and water solubility of 4.16 × 10-5 g/mL.

cysteinyl leukotrienecysteinyl leukotriene receptor 1(CysLT1R)selective antagonists

王婧怡、刘金羽、陈东升、陈华燕、谢欣、南发俊

展开 >

中国科学院大学 北京 100049

中国科学院上海药物研究所 上海 201203

南京中医药大学 南京 210023

半胱氨酰白三烯 半胱氨酰白三烯受体1(CysLT1R) 选择性拮抗剂

国家自然科学基金

82003571

2024

有机化学
中国化学会,中国科学院上海有机化学研究所

有机化学

CSTPCD北大核心
影响因子:1.09
ISSN:0253-2786
年,卷(期):2024.44(1)
  • 26